|
62 Companies |
|
89 Products |
|
89 Products |
|
76 Mechanisms of Action |
|
2 Trials |
|
652 News |
|
| «12...234567891011121314 |
- Trial withdrawal: Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum (clinicaltrials.gov) - Aug 28, 2011
P=N/A, N=60, Withdrawn, Sponsor: Meir Medical Center
Recruiting --> Withdrawn
- Enrollment change: RPD: Reciprocating Medical Devices - a Study of a New Safety Device (clinicaltrials.gov) - Aug 28, 2011
P=N/A, N=437, Completed, Sponsor: University of New Mexico
Recruiting --> Withdrawn N=820 --> 437
- Trial completion: RPD: Reciprocating Medical Devices - a Study of a New Safety Device (clinicaltrials.gov) - Aug 28, 2011
P=N/A, N=437, Completed, Sponsor: University of New Mexico
N=820 --> 437 Recruiting --> Completed
- || carbimazole / Generic mfg., propylthiouracil / Generic mfg.
New P3 trial: Antithyroid Drug Treatment of Thyrotoxicosis in Young People (clinicaltrials.gov) - Aug 17, 2011
P3, N=160, Recruiting, Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
- | Votrient (pazopanib) / Novartis, BeiGene
New P1 trial, Combination therapy, Surgery, Metastases: Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery (clinicaltrials.gov) - Aug 8, 2011
P1, N=24, Active, not recruiting, Sponsor: University of Washington
- | Enrollment closed: Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer (clinicaltrials.gov) - Aug 8, 2011
P2/3, N=74, Active, not recruiting, Sponsor: University Health Network, Toronto
Recruiting --> Completed Recruiting --> Active, not recruiting